References

Ács N, Bánhidy F, Puhó E and Czeizel AE (2006). A possible dose-dependent teratogenic effect of ergotamine. Reprod Toxicol, 22(3): 551-2. https://doi.org/10.1016/j.reprotox.2006.03.002

Aellig WH and Nüesch E (1977). Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man. Int J Clin Pharmacol Biopharm. 15(3):106-12. PMID: 403149. Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man - PubMed

Arroyo-Manzanares N, Gámiz-Gracia L, García-Campaña AM,  Di Mavungu JD, De Saeger S (2017). Ergot Alkaloids: Chemistry, Biosynthesis, Bioactivity, and Methods of Analysis. Fungal Metabolites 887-929 https://doi.org/10.1007/978-3-319-25001-4_

Agriopoulou S (2021). Ergot Alkaloids Mycotoxins in Cereals and Cereal-Derived Food Products: Characteristics, Toxicity, Prevalence, and Control Strategies. Agronomy. 11. 931. Ergot Alkaloids Mycotoxins in Cereals and Cereal-Derived Food Products: Characteristics, Toxicity, Prevalence, and Control Strategies

Bates B, Lennox A, Prentice A, Bates C, Page P, Nicholson S, Swan G (2014). National Diet and Nutrition Survey Results from Years 1, 2, 3 and 4 (combined) of the Rolling Programme (2008/2009 – 2011/2012) National Diet and Nutrition Survey Results from Years 1, 2, 3 and 4 (combined) of the Rolling Programme (2008/2009 – 2011/2012

Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, Swan G (2016). National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014) National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014)

Bernard N, Jantzem H, Becker M, Pecriaux C, Bénard-Laribière A, Montastruc JL, Descotes J, Vial T (2015). Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey. Royal College of Obstetricians and Gynaecologists, 122(9): 1244-51. https://doi.org/10.1111/1471-0528.13352

Bogun N, Mathies R, Baesecke J (2011). Angiospastic occlusion of the superficial femoral artery by chronic ergotamine intake. Deutsche Medizinische Wochenschrift, 136(1-2): 23-6. https://doi.org/10.1055/s-0030-1269435

Bryła M, Szymczyk K, Jędrzejczak R, Roszko M (2015). Application of liquid chromatography/ ion trap mass spectrometry technique to determine ergot alkaloids in grain products. Food Technol Biotechnol 53:18–28. https://doi.org/10.17113/ftb.53.01.15.3770

Britt JL, Greene MA, Bridges Jr WC, Klotz JL, Aiken GE, Andrae JG, Pratt SL, Long NM, Schrick FN, Strickland JR, Wilbanks SA, Miller Jr MF, Koch BM, Duckett SK (2019). Ergot alkaloid exposure during gestation alters. I. Maternal characteristics and placental development of pregnant ewes. Journal of Animal Science, 97(4):1874–90. https://doi.org/10.1093%2Fjas%2Fskz068

Bryła M, Szymczyk K, Jędrzejczak R, Roszko M (2015). Application of liquid chromatography/ ion trap mass spectrometry technique to determine ergot alkaloids in grain products. Food Technol Biotechnol 53:18–28. https://doi.org/10.17113/ftb.53.01.15.3770

Caraballo D, Toloso J, Ferrer E, Berrada H (2019). Dietary exposure assessment to mycotoxins through total diet studies. A review. Food and Chemical Toxicology, 128: 8-20. https://doi.org/10.1016/j.fct.2019.03.033

Carbonell-Rozas L, Gamiz-Gracia L, Lara FJ, Garcia-Campana AM (2021). Determination of the main ergot alkaloids and their epimers in oat-based functional foods by ultra-high performance liquid chromatography tandem mass spectrometry. Molecules, 26(12): 3717. https://doi.org/10.3390/molecules26123717

Cassady JM, Li GS, Spitzner EB, Floss H, Clemens JA (1974). Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release. J Med Chem. (3):300-7. https://doi.org/10.1021/jm00249a009

Cozzolino M, Riviello C, Fichtel G, Di Tommaso M (2016). Brief Report Exposure to Methylergonovine Maleate as a Cause of Sirenomelia. Birth Defects Research Part A: Clinical and Molecular Teratology, 106(7): 643-7. https://doi.org/10.1002/bdra.23503

Commission Regulation (EU) 2021/1399 of 24 August 2021 amending Regulation (EC) No 1881/2006 as regards maximum levels of ergot sclerotia and ergot alkaloids in certain foodstuffs (Text with EEA relevance).  Regulation - 2021/1399 - EN - EUR-Lex

COT (2017). Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. tox2017-30_0.pdf

Crews C, Anderson WAC, Rees G, Krska R (2009). Ergot alkaloids in some rye-based UK cereal products. Food Addit Contam Part B Surveill 2:79–85. https://doi.org/10.1080/02652030903042509

Czeizel A (1989). Teratogenicity of ergotamine. J Med Genet 26(1):69-70

http://dx.doi.org/10.1136/jmg.26.1.69-a

Della-Giustina K and Chow G (2003). Medications in pregnancy and lactation. Emergency Medicine Clinics of North America, 21(3): 585-613.

https://doi.org/10.1016/s0733-8627(03)00037-3

De Ruyck K, De Boevre M, Huybrechts I, De Saeger S (2015). Dietary mycotoxins, co-exposure, and carcinogenesis in humans: Short review. Mutation Research/Reviews in Mutation Research, 766: 32-41. https://doi.org/10.1016/j.mrrev.2015.07.003

DH (2013). Diet and Nutrition Survey of Infants and Young Children (DNSIYC), 2011.

Diet and nutrition survey of infants and young children, 2011 - GOV.UK

Dighe R and Vaidya VG (1988). Induction of sister chromatid exchanges by ergot compounds in Chinese hamster ovary cells in vitro. Teratog. Carcinog. Mutagen. 8, 169–174. https://doi.org/10.1002/tcm.1770080306

Duckett SK, Andrae JG, Prat SL (2014). Exposure to Ergot alkaloids during gestation reduces fetal growth in sheep. Frontiers in Chemistry, 21: 2:68. https://doi.org/10.3389/fchem.2014.00068

Dusemund B, Altmann H-J and Lampen A, (2006). II. Toxikologische Bewertung Mutterkornalkaloidkontaminierter Roggenmehle. Journal of Consumer Protection and Food Safety, 1, 150-152. „ „Mutterkornalkaloide in Lebensmitteln“ | Journal of Consumer Protection and Food Safety | Springer Nature Link

Eckert H, Kiechel JR, Rosenthaler J, Schmidt R, Schreier E (1978). Biopharmaceutical Aspects. In: Berde, B., Schild, H.O. (eds) Ergot Alkaloids and Related Compounds. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 49. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66775-6_11

EFSA (2005). Opinion of the Scientific Panel on Contaminants in Food Chain on a request from the Commission related to ergot as undesirable substance in animal feed. EFSA Journal (2005)225, 1 – 27. Opinion of the Scientific Panel on contaminants in the food chain [CONTAM] related to ergot as undesirable substance in animal feed - - 2005 - EFSA Journal - Wiley Online Library

EFSA (2012). Scientific Opinion on Ergot alkaloids in food and feed. EFSA Journal, 10(7): 2798. https://doi.org/10.2903/j.efsa.2012.2798

Fayrer-Hosken R., Stanley A., Hill N., Heusner G., Christian M., De La Fuente R., Baumann C., Jones L. (2012). Effect of feeding fescue seed containing ergot alkaloid toxins on stallion spermatogenesis and sperm cells. Reprod Domest Anim 47(6): 1017-26. https://doi.org/10.1111/j.1439-0531.2012.02008.x

Fayrer-Hosken RA, Hill NS, Heusner GL, Traylor-Wiggins W, Turner K (2013). The effects of ergot alkaloids on the breeding stallion reproductive system. Equine Vet J Suppl 12 (45):44-7. https://doi.org/10.1111/evj.12164

Fitzgerald P and Dinan TG (2008). Prolactin and dopamine: what is the connection? A review article. Journal of Psychopharmacology, 22(2 Suppl), 12-9. https://doi.org/10.1177/0269216307087148

Fröhlich G, Kaplan V, Amann-Vesti B (2010). Holy fire in an HIV-positive man: a case of 21^st century ergotism. Canadian Medical Association Journal, 182 (4): 378-80. https://doi.org/10.1503%2Fcmaj.091362

FSA (2014). Monitoring the Presence of Ergot Alkaloids in Cereals and a Study of a Possible Relationship between Occurrence of Sclerotia Content and Levels of Ergot Alkaloids. Monitoring the presence of ergot alkaloids in cereals | Food Standards Agency

Garcia GD, Goff Jr JM, Hadro NC, I-Donnell SD, Greatorex PS (2000). Chronic ergot toxicity: A rare cause of lower extremity ischemia. Journal of Vascular Surgery, 31(6): 1245-7. https://doi.org/10.1067/mva.2000.105668

Gerhards N, Neubauer L, Tudzynski P, Li SM (2014). Biosynthetic Pathways of Ergot Alkaloids. Toxins, 6(12):3281-95. https://doi.org/10.3390%2Ftoxins6123281

Graf WD and Shepard TH (1997). Uterine contraction in the development of Möbius syndrome. Journal of Child Neurology,12(3): 225-7. https://doi.org/10.1177/088307389701200315

Greene MA, Britt JL, Powell RP, Feltus FA, Bridges WC, Bruce T, Klotz JL, Miller MF, Duckett SK (2019). Ergot alkaloid exposure during gestation alters: 3. Fetal growth, muscle fiber development, and miRNA transcriptome. Journal of Animal Science, 97(7):3153-68. https://doi.org/10.1093/jas/skz153

Griffith RW, Grauwiler J, Hodel Ch, Leist KH, Matter B, (1978). In: Berde, B., Schild, H.O. (Eds.), Toxicologic Considerations. Ergot Alkaloids and Related Compounds. Springer Verlag, Berlin, Heidelberg, New York, pp. 805–851, abstract only. https://doi.org/10.1007/978-3-642-66775-6

Guggisberg H (1954). Changes in the therapeutic use of ergot. Ther Umsch. 11(4):77-9.

Haarmann T, Ortel I, Tudzynski P, Keller U (2006). Identification of the cytochrome P450 monooxygenase that bridges the clavine and ergoline alkaloid pathways. ChemBioChem – Chemistry Europe. 7(4):645-52. https://doi.org/10.1002/cbic.200500487

Hardman J, Limbird L, Gilman A (2001). The pharmacological basis of therapeutics. Goodman & Gilman’s 10th ed. New York: McGraw-Hill. Anesthesia & Analgesia

Harleman J, Hargreaves A, Andersson H, Kirk S (2012). A Review of the Incidence and Coincidence of Uterine and Mammary Tumors in Wistar and Sprague-Dawley Rats Based on the RITA Database and the Role of Prolactin. Toxicologic Pathology. 40(6):926-930. https://doi.org/10.1177/0192623312444621

Janssen GB, Beems RB, Elvers LH, Speijers GJ (2000). Subacute toxicity of α-ergocryptine in Sprague-Dawley rats. 2: metabolic and hormonal changes. Food Chem Toxicol. 38:689–95. https://doi.org/10.1016/S0278-6915(00)00055-7

JECFA (2021). Safety evaluation of certain food additives and contaminants. Summary report of the ninety-first meeting. Evaluation of certain food additives and contaminants: ninety-first report of the Joint FAO/WHO Expert Committee on Food Additives

JECFA (2023). Safety evaluation of certain contaminants in food: prepared by the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (‎JECFA)‎. Safety evaluation of certain contaminants in food: prepared by the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (‎JECFA)‎

Jolivet A, Robyn C, Huraux-Rendu C, Gautray JP (1978). Effect of ergot alkaloid derivatives on milk secretion in the immediate postpartum period. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 7(1):129-134.

Kjeldgaard Pedersen L, Rikke Damkjær Maimburg R, Hertz JM, Gjørup H, Klit Pedersen T, Møller-Madsen B, Rosendahl Østergaard J (2017). Moebius sequence – a multidisciplinary clinical approach. Orphanet Journal of Rare Diseases, 12(1):4. https://doi.org/10.1186/s13023-016-0559-z

Klotz J (2015). Activities and Effects of Ergot Alkaloids on Livestock Physiology and Production. Toxins (Basel) 7(8), 2801-2821. https://doi.org/10.3390/toxins7082801 

Klotz JL, Britt JL, Miller MF, Snider MA, Aiken GE, Long NM, Pratt SL, Andrae GJ, Duckett SK (2019). Ergot alkaloid exposure during gestation alters: II. Uterine and umbilical artery vasoactivity. Journal of Animal Science, 97(4): 1891-1902. https://doi.org/10.1093/jas/skz069

Korn AK, Gross M, Usleber E Thom N, Köhler K, Erhardt G (2014). Dietary ergot alkaloids as a possible cause of tail necrosis in rabbits. Mycotoxin Residues, 30(4):241–50. https://doi.org/10.1007%2Fs12550-014-0208-0

Krska R and Crews C (2008). Significance, chemistry and determination of ergot alkaloids: a review. Food Additives and Contaminants: Part A, chemistry, analysis, control, exposure and risk assessment, 25(6):722-31. https://doi.org/10.1080/02652030701765756

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Monir Islam Q (2018). Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev 7;6(6):CD005456. https://doi.org/10.1002/14651858.CD005456.pub3

Lieberman AN and Goldstein M (1985). Bromocriptine in Parkinson disease. Pharmacological Review. 37(2) 217-27. Bromocriptine in Parkinson disease - PubMed

Little PJ, Jennings GL, Skews H, Bobik A (1982). Bioavailability of dihydroergotamine in man. Br J Clin Pharmacol, 13(6):785-90. https://doi.org/10.1111/j.1365-2125.1982.tb01866.x

MacLeod RM and Lehmeyer J (1973). Suppression of Pituitary Tumor Growth and Function by Ergot Alkaloids. Cancer Research 33, 849-855.

Mrusek M, Seo E-J, Greten HJ, Simon M, Efferth T (2015). Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids. Invest New Drugs. 33(1):32-44. https://doi.org/10.1007/s10637-014-0168-4

Mulac D and Humpf HU (2011). Cytotoxicity and accumulation of ergot alkaloids in human primary cells. Toxicology, 282(3):112–21. https://doi.org/10.1016/j.tox.2011.01.019

Müller C, Kemmlein S, Klaffke H, Krauthause W, Preiss-Weigert A, Wittkowski R (2009). A basic tool for risk assessment: a new method for the analysis of ergot alkaloids in rye and selected rye products. Mol Nutr Food Res 53:500–507 https://doi.org/10.1002/mnfr.200800091

Olver IN, Jennings GL, Bobik A, Esler M (1980). Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. British Medical Journal. 281(6235):275-276. https://doi.org/10.1136/bmj.281.6235.275-a

Orton DA and Richardson RJ (1982). Ergotamine absorption and toxicity. Postgraduate Medical Journal, 58(675): 6-11. https://doi.org/10.1136%2Fpgmj.58.675.6

Page R, Lester T, Rorie R, Rosenkrans Jr C (2019). Ergot Alkaloid Effects on Bovine Sperm Motility In Vitro. Advance in Reproductive Science, 7(1): 7-15. https://doi.org/10.4236/arsci.2019.71002

Poole R and Poole DH (2019). Impact of Ergot Alkaloids on Female Reproduction in Domestic Livestock Species. Toxins, 11(6): 364. https://doi.org/10.3390/toxins11060364

Prendiville WJ, Elbourne D, McDonals S (2000). Active versus expectant management in the third stage of labor. Cochrane Database Systematic Reviews, 3. https://doi.org/10.1002/14651858.cd000007

Perrin VL (1985). Clinical pharmacokinetics of ergotamine in migraine and cluster headache. Clinical Pharmacokinetics 10(4): 334–52. https://doi.org/10.2165/00003088-198510040-00004

Reinhold L, Reinhardt K (2011). Mycotoxins in foods in Lower Saxony (Germany): results of official control analyses performed in 2009. Mycotoxin Res 27:137–143. https://doi.org/10.1007/s12550-011-0086-7

Roberts C, Steer, T, Maplethorpe N, Cox L, Meadows S, Page P, Nicholson S, Swan G (2018). National Diet and Nutrition Survey Results from Years 7 and 8 (combined) of the Rolling Programme (2014/2015 – 2015/2016) National Diet and Nutrition Survey

Roberts G and Rand MJ (1977). Chromosomal damage induced by some ergot derivatives in vitro. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 48 (2):205-214. https://doi.org/10.1016/0027-5107(77)90162-2

Schardl CL, Panaccione DG and Tudzynski P, 2006. Ergot Alkaloids - Biology and Molecular Biology. In:  The Alkaloids: Chemistry and Biology. Vol.  63.  Ed Cordell GA.  Academic Press, San Diego, USA, 45-86.

Schiff PL (2006). Ergot and its alkaloids. Am J Pharm Educ 70(5):98. https://doi.org/10.5688/aj700598

Seifried, H.E., Seifried, R.M., Clarke, J.J., Junghans, T.B., San, R.H.C. (2006). A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays. Chem. Res. Toxicol. 19, 627–644. https://doi.org/10.1021/tx0503552

Shaar CJ and Clemens JA (1972). Inhibition of lactation and prolactin secretion in rats by ergot alkaloid. Endocrinology. 90:285–88 [abstract only]. https://doi.org/10.1210/endo-90-1-285

Silberstein SD and McCrory DC (2003). Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache, 43(2): 144-66. https://doi.org/10.1046/j.1526-4610.2003.03034.x

Smets K, Zecic A, Willems J (2004). Ergotamine as a possible cause of Möbius sequence: additional clinical observation. Journal of Child Neurology, 19(5): 398. https://doi.org/10.1177/088307380401900518

Storm ID, Have Rasmussen P, Strobel BW, Hansen HCB (2008). Ergot alkaloids in rye flour determined by solid-phase cation-exchange and high-pressure liquid chromatography with fluorescence detection. Food Addit Contam 25:338–346. https://doi.org/10.1080/02652030701551792

Stratton J, Anderson S, Leon I, Hepworth P, Chapman S, Christy J, Jardine S, Philips D, Setter R, Clough J, MacDonals S (2017). Diet Study (TDS) – Mycotoxin Analysis. Final Report, FS102081. Fera Science Ltd, York (UK). Diet Study (TDS) – Mycotoxin Analysis Report, 2017 - Search

Tasker NR and Wipf P (2021). Biosynthesis, total synthesis, and biological profiles of Ergot alkaloids. Alkaloids Chemical Biology, 85:1-112. https://doi.org/10.1016/bs.alkal.2020.08.001

Tfelt-Hansen, P., Saxena, P.R., Dahlof, C., Pascual, J., Lainez, M., Henry, P.,Diener, H.,Schoenen, J., Ferrari, M.D., Goadsby, P.J., (2000). Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123 (Pt 1), 9–18. https://doi.org/10.1093/brain/123.1.9

Valente Eel, Klotz JL, Ahn G, McLeod KR, Herzing HM, King M, Harmon DL (2020). Ergot alkaloids reduce circulating serotonin in the bovine. Journal of Animal Science, 98(12). https://doi.org/10.1093/jas/skaa362

Wyss PA, Rosenthaler J, Nüesch E, Aellig WH (1991).  Pharmacokinetic investigation of oral and IV dihydroergotamine in healthy subjects. Eur J Clin Pharmacol 41, 597–602. https://doi.org/10.1007/BF00314992

Young CA, Schardl CL, Panaccione DG, Florea S, Takach JE, Charlton ND, Moore N, Webb JS, Jaromczyk J (2015). Genetics, Genomics and Evolution of Ergot Alkaloid Diversity. Toxins (Basel). Apr 14;7(4):1273–1302. https://doi.org/10.3390/toxins7041273

Zeilmaker GH and Carlsen RA (1962). Experimental studies on the effect of ergocornine methanesulphonate on the luteotrophic function of the rat pituitary gland.  Acta Endocrinol (Copenh) 41:321-35. https://doi.org/10.1530/acta.0.0410321